Department of Pediatrics, University of New Mexico School of Medicine, Albuquerque, New Mexico, USA.
Am J Med Genet A. 2011 Feb;155A(2):337-42. doi: 10.1002/ajmg.a.33807. Epub 2010 Dec 22.
Poikiloderma with Neutropenia (PN), Clericuzio-Type (OMIM #604173) is characterized by poikiloderma, chronic neutropenia, recurrent sinopulmonary infections, bronchiectasis, and nail dystrophy. First described by Clericuzio in 1991 in 14 patients of Navajo descent, it has since also been described in non-Navajo patients. C16orf57 has recently been identified as a causative gene in PN. The purpose of our study was to describe a spectrum of C16orf57 mutations in a cohort of PN patients including five patients of Athabaskan (Navajo and Apache) ancestry. Eleven patients from eight kindreds were enrolled in an IRB-approved study at Baylor College of Medicine. Five patients were of Athabaskan ancestry. PCR amplification and sequencing of the entire coding region of the C16orf57 gene was performed on genomic DNA. We identified biallelic C16orf57 mutations in all 11 PN patients in our cohort. The seven new deleterious mutations consisted of deletion (2), nonsense (3), and splice site (2) mutations. The patients of Athabaskan ancestry all had a common deletion mutation (c.496delA) which was not found in the six non-Athabaskan patients. Mutations in the C16orf57 gene have been identified thus far in all patients studied with a clinical diagnosis of PN. We have identified seven new mutations in C16orf57 in PN patients. One of these is present in all patients of Athabaskan descent, suggesting that c.496delA represents the PN-causative mutation in this subpopulation.
斑丘状中性粒细胞减少症(PN),Clericuzio 型(OMIM #604173)的特征是斑丘状皮肤改变、慢性中性粒细胞减少症、反复的肺和鼻窦感染、支气管扩张和指甲营养不良。该疾病由 Clericuzio 于 1991 年首次在 14 名具有纳瓦霍人血统的患者中描述,此后也在非纳瓦霍人患者中被描述过。最近已鉴定出 C16orf57 是 PN 的致病基因。我们的研究目的是描述一组包括 5 名 Athabaskan(纳瓦霍人和阿帕切人)血统的 PN 患者的 C16orf57 基因突变谱。在贝勒医学院进行的一项 IRB 批准的研究中,招募了来自 8 个家族的 11 名患者。其中 5 名患者具有 Athabaskan 血统。对基因组 DNA 进行 C16orf57 基因全长编码区的 PCR 扩增和测序。我们在我们的队列中的 11 名 PN 患者中均发现了 C16orf57 基因的双等位基因突变。这 7 个新的有害突变包括缺失(2)、无义(3)和剪接位点(2)突变。Athabaskan 血统的患者均具有共同的缺失突变(c.496delA),而在 6 名非 Athabaskan 患者中未发现该突变。迄今为止,在所有具有 PN 临床诊断的患者中均已鉴定出 C16orf57 基因突变。我们在 PN 患者的 C16orf57 中发现了 7 个新突变。其中一个存在于所有 Athabaskan 血统的患者中,表明 c.496delA 代表该亚群的 PN 致病突变。